Can 'Teach-Back' cut hospital returns after anal fistula surgery?
NCT ID NCT07323160
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using the 'teach-back' method—where patients repeat back what they've learned—improves understanding and reduces readmissions after same-day anal fistula surgery. Half of the 76 participants will get this interactive education, while the other half receives standard instructions. Researchers will compare readmission rates and satisfaction scores over 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
teach-back discharge education
What this could lead to
If it works, this could point toward a simple, low-cost way to improve patient understanding and reduce hospital returns after anal fistula surgery.
What could go wrong
This is a small, early-stage study (76 people) testing an educational method, not a drug or device. Results may not apply to other surgeries or hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL FISTULA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••